Pulse Biosciences Inc expected to post a loss of 53 cents a share - Earnings Preview

Pulse Biosciences

12/11/2021 23:05

* Pulse Biosciences Inc  PLSE.OQ   PLSE.O  is expected to show a
rise in quarterly revenue when it reports  results on November
15. 
* The Hayward, California-based company is expected to report
revenue of $188.67 thousand, according to the mean estimate from
3 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Pulse Biosciences Inc
is for a loss of 53 cents per share. For the same quarter last
year, the company reported a loss of 51 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Pulse
Biosciences Inc is $40​, about 45.9% above​ its last closing
price of $21.63. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.68       -0.69      -0.58     Beat    16.3
 Mar. 31 2021  -0.49       -0.49      -0.71     Missed  -43.4
 Dec. 31 2020  -0.45       -0.45      -0.54     Missed  -20​
 Sep. 30 2020  -0.44       -0.44      -0.51     Missed  -15.9
 ​​Jun.        -0.50       -0.50      -0.53     Missed  -6
 30 2020                                                
 Mar. 31 2020  -0.47       -0.47      -0.57     Missed  -21.3​
 Dec. 31 2019              -0.61      -0.66     Missed  -8.2
 Sep. 30 2019  -0.61       -0.61      -0.57     Beat    6.6
 This summary was machine generated November 12 at 23:05 GMT. 
All figures in US dollars  unless otherwise stated